liver neoplasm: A benign or malignant epithelial neoplasm that affects the liver parenchyma and intrahepatic bile ducts. Representative examples of benign epithelial neoplasms include hepatocellular adenoma and intrahepatic bile duct adenoma. Representative examples of malignant epithelial neoplasms include hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
786 |
4. Check minimum number of eventsNone |
786 |
5. Include endpointsNone |
786 |
6. Filter based on genotype QC (FinnGen only) |
786 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D13
- Name in latin
- Neoplasma benignum hepatis
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Liver
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Liver
- Benign neoplasm: Liver/bile ducts
- Benign neoplasm: Liver/bile ducts
- Benign neoplasm of other and ill-defined parts of digestive system
- Benign neoplasm of other and ill-defined parts of digestive system
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3928 | 2744 | 1154 |
| Only index persons | 3579 | 2565 | 1014 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.06 | 0.08 | 0.03 |
| Only index persons | 0.08 | 0.09 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 51.46 | 48.25 | 58.77 |
| Only index persons | 50.04 | 46.94 | 57.87 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 786 | 574 | 212 |
| Unadjusted period prevalence (%) | 0.17 | 0.20 | 0.09 |
| Median age at first event (years) | 52.28 | 48.71 | 61.94 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 677
- Matched controls
- 6768
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D13.4
ICD-10 Finland
Benign neoplasm: Liver
4503599627370496.0
323.0
666
*
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
86.8
145.6
160
24
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
25.6
96.8
138
67
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
15.5
58.6
99
74
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
6.2
50.0
147
288
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
19.3
49.3
76
44
R93.2
ICD-10 Finland
Abnormal findings on diagnostic imaging of liver and biliary tract
38.5
31.9
40
11
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.6
28.9
314
1700
R10.1
ICD-10 Finland
Pain localized to upper abdomen
3.1
26.1
165
633
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
7.5
24.0
58
84
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
22.5
228
1148
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.3
19.8
108
366
K76.89
ICD-10 Finland
Other specified diseases of liver
43.2
17.4
21
5
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
28.3
16.6
22
8
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
13.2
16.3
28
22
D18.0
ICD-10 Finland
Haemangioma, any site
7.1
16.0
39
58
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.7
16.0
123
522
UJF32
NOMESCO Finland
Coloscopy
2.2
15.9
193
1031
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
6.4
13.5
35
57
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
12.6
12.7
22
18
JJB71
NOMESCO Finland
Laparoscopic resection of liver
+∞
12.5
12
*
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.0
12.2
181
1038
A02BC02
ATC
pantoprazole; systemic
1.8
12.1
435
3373
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
16.8
11.7
18
11
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
30.6
11.7
15
5
21150
ICD-8 Finland
Benign neoplasm of other parts of digestive system, Hepatis
+∞
11.5
11
*
J01MA02
ATC
ciprofloxacin; systemic
1.7
10.1
255
1740
K76.80
ICD-10 Finland
Hepatic cyst
8.8
9.3
19
22
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.2
9.2
92
444
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
8.9
183
1161
A02BC03
ATC
lansoprazole; oral
1.8
8.8
188
1208
N02AX02
ATC
tramadol; systemic, rectal
1.7
8.7
267
1902
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
16.5
8.6
13
8
JJ3AT
NOMESCO Finland
Cytology of liver with ultrasound guidance
27.9
8.5
11
*
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
27.9
8.5
11
*
A02BC05
ATC
esomeprazole; systemic
1.6
8.3
262
1878
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
8.3
119
666
K76.9
ICD-10 Finland
Liver disease, unspecified
6.9
8.1
19
28
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
11.9
8.1
14
12
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
11.0
7.8
14
13
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.0
7.7
100
534
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
5.0
7.6
23
47
N02BE01
ATC
paracetamol; systemic, rectal
1.8
7.6
568
5041
130
Kela drug reimbursment
Malignant tumour
2.6
7.6
55
223
A06AC01
ATC
ispaghula (psylla seeds); oral
1.8
7.5
154
969
JN4CD
NOMESCO Finland
Very extensive body CT
3.6
7.5
32
92
P01AB01
ATC
metronidazole; oral, rectal
1.6
7.4
272
2012
ZXE20
NOMESCO Finland
More than three and less than five hours
2.0
7.2
91
483
R51.80
ICD-10 Finland
Headache
1.9
7.2
107
606
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
5.4
7.1
20
38
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.8
7.0
42
155
R06.0
ICD-10 Finland
Dyspnoea
1.7
6.9
153
983
B01AB05
ATC
enoxaparin; parenteral
1.6
6.8
188
1288
JJB30
NOMESCO Finland
Excision of two segments of liver
40.4
6.8
8
*
K30
ICD-10 Finland
Functional dyspepsia
2.1
6.7
73
364
A02BC01
ATC
omeprazole; systemic
1.7
6.7
174
1168
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
4.0
6.7
25
64
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
22.8
6.7
9
*
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
2.9
6.7
38
134
JJA21
NOMESCO Finland
Laparoscopic biopsy of liver
12.4
6.6
11
9
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
2.0
6.5
86
465
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.0
6.5
82
435
UKC02
NOMESCO Finland
Cystoscopy
2.0
6.5
89
485
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
6.5
142
910
D13.9
ICD-10 Finland
Benign neoplasm: Ill-defined sites within the digestive system
70.5
6.4
7
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
6.2
248
1853
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.2
6.1
57
267
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
6.0
133
852
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
146
74
24.00
194.59
1.8
2.1
u/ml
3.5
59.4
0.51
146
68
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
154
209
8.92
111.16
2.2
3.2
u/ml
11.0
1370.9
0.98
136
181
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
251
569
6.01
111.05
2.5
4.0
ug/l
2.6
14.6
0.92
170
458
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
584
3256
4.09
68.98
6.8
5.7
umol/l
10.4
10.6
0.18
561
3087
(40768441) Liver Pathology biopsy report
64
48
14.43
68.91
1.3
1.2
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
84
101
9.19
65.87
1.9
4.1
u/ml
143.9
453.1
0.57
77
96
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
194
564
4.24
60.29
2.4
2.1
g/l
0.2
0.2
0.61
187
530
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
220
705
3.94
59.64
3.9
2.4
umol/l
5.2
6.8
1.92
194
613
(3024561) Albumin [Mass/volume] in Serum or Plasma
462
2548
2.97
48.53
5.6
4.3
g/l
36.2
36.2
0.09
438
2385
(3032080) INR in Blood by Coagulation assay
424
2256
2.91
47.23
7.0
7.4
inr
1.2
1.2
0.01
91
691
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
684
4905
4.04
42.15
9.4
7.0
u/l
79.3
76.2
1.47
659
4619
(3033658) Prothrombin time (PT) actual/Normal
317
1565
2.72
38.95
5.7
3.4
%
96.8
94.4
0.87
309
1513
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
355
1991
2.43
31.83
3.2
2.4
u/l
56.7
56.0
0.10
327
1850
(3007566) Smooth muscle Ab [Titer] in Serum
73
165
4.77
30.54
1.3
1.1
titre
52.5
88.6
—
8
14
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
374
2204
2.33
29.27
4.2
3.1
u/l
30.5
29.7
0.24
361
2105
(3034770) Mitochondria Ab [Titer] in Serum
70
175
4.29
25.75
1.3
1.2
—
760.0
—
0
5
(3013826) Glucose [Moles/volume] in Serum or Plasma
508
3589
2.17
23.34
6.1
4.4
mmol/l
6.6
6.5
0.20
487
3315
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
269
1520
2.17
21.85
2.4
2.1
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
111
434
2.81
20.19
8.0
7.1
mmol/l
7.7
8.9
0.89
105
416
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
442
3079
2.00
19.63
4.0
3.8
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
322
2028
2.00
18.92
2.5
2.1
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
168
838
2.28
18.14
2.9
2.2
g/l
2.5
2.4
1.10
157
774
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
158
770
2.32
18.02
3.1
2.2
%
23.9
23.0
0.31
145
665
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
583
4549
2.09
17.99
4.4
2.9
u/l
60.2
42.9
5.45
561
4296
(3022948) Iron [Moles/volume] in Serum or Plasma
176
911
2.20
17.30
3.0
2.2
umol/l
14.2
13.6
0.49
167
836
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
385
2655
1.88
16.62
7.8
5.5
mmol/l
1.2
1.2
0.06
355
2411
(3013650) Neutrophils [#/volume] in Blood by Automated count
499
3751
1.90
16.32
8.7
8.7
e9/l
4.4
4.0
3.06
432
3311
(3013707) Erythrocyte sedimentation rate by Westergren method
600
4810
2.05
16.07
4.3
3.9
mm/h
11.8
10.8
0.88
561
4486
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
414
2952
1.85
15.79
8.6
6.1
mmol/l
1.2
1.2
0.02
371
2475
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
744
6577
3.46
15.24
16.8
12.3
mg/l
23.7
21.2
1.13
643
5147
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
16
15
10.87
14.68
1.4
3.9
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
120
566
2.32
14.58
3.1
2.3
u/l
31.4
36.1
0.58
98
480
(3019198) Lymphocytes [#/volume] in Blood
448
3331
1.80
14.35
6.1
5.5
e9/l
2.5
1.9
0.56
388
2988
(3014576) Chloride [Moles/volume] in Serum or Plasma
133
663
2.21
14.14
9.7
6.8
mmol/l
105.1
104.3
1.42
133
652
(3013115) Eosinophils [#/volume] in Blood
449
3356
1.79
13.97
6.3
5.8
e9/l
0.2
0.2
0.40
383
2991
(3019550) Sodium [Moles/volume] in Serum or Plasma
743
6620
3.24
13.85
18.5
13.5
mmol/l
139.6
139.6
0.06
734
6448
(3001604) Monocytes [#/volume] in Blood
435
3231
1.78
13.74
6.1
5.5
e9/l
0.6
0.6
0.60
371
2835
(3006315) Basophils [#/volume] in Blood
436
3245
1.77
13.63
6.1
5.5
e9/l
0.0
0.0
0.32
372
2847
(3023103) Potassium [Moles/volume] in Serum or Plasma
743
6633
3.20
13.54
18.6
13.6
mmol/l
3.9
3.9
1.73
733
6447
(3031040) Bacteria [#/volume] in Urine by Automated count
534
4249
1.80
12.95
5.0
4.1
e6/l
439.7
1907.6
—
6
61
(3003458) Phosphate [Moles/volume] in Serum or Plasma
138
724
2.10
12.81
6.1
5.1
mmol/l
1.0
1.0
0.21
126
670
(3007164) IgA [Mass/volume] in Serum or Plasma
221
1371
1.85
12.58
1.6
1.5
g/l
2.1
2.3
0.77
149
862
(42870588) Differential panel, method unspecified - Blood
304
2090
1.74
12.15
6.3
5.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
95
439
2.32
12.03
3.8
3.5
ng/l
77.7
79.9
0.12
79
396
(3037522) Nuclear Ab [Titer] in Serum
161
925
1.93
11.51
1.5
1.3
titre
615.8
524.0
0.24
38
209
(4035726)
104
513
2.18
11.25
1.4
1.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
151
858
1.94
11.13
2.0
1.7
%
1.4
1.4
0.44
136
772
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
241
1587
1.75
11.01
1.4
1.2
u/ml
0.6
1.7
2.25
72
437
(3002030) Lymphocytes/100 leukocytes in Blood
412
3131
1.66
10.98
6.3
5.6
%
28.8
28.6
0.11
389
2936
(3037467) Urinalysis macro (dipstick) panel - Urine
547
4488
1.72
10.78
4.6
4.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
305
2154
1.68
10.72
4.4
3.4
e6/l
36.9
87.0
1.45
206
1460
(36304419) Bacteria [Presence] in Urine
240
1590
1.73
10.68
3.2
2.8
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
151
875
1.90
10.44
2.0
2.3
ug/g
124.8
113.2
0.18
116
695
(3018010) Neutrophils/100 leukocytes in Blood
406
3105
1.64
10.31
6.2
5.3
%
57.8
56.9
0.87
384
2920
(3019069) Monocytes/100 leukocytes in Blood
399
3040
1.63
10.28
6.6
5.8
%
7.9
8.3
2.23
377
2862
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
153
895
1.88
10.27
3.4
2.7
e6/l
3.1
3.1
0.00
80
468
(3006504) Eosinophils/100 leukocytes in Blood
397
3025
1.63
10.19
6.3
5.5
%
2.6
2.8
1.12
375
2827
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
228
1510
1.72
10.06
2.2
1.7
mg/l
1.1
1.1
0.01
179
1133
(3022096) Basophils/100 leukocytes in Blood
384
2913
1.62
9.96
6.3
5.6
%
0.6
0.7
0.50
361
2724
(3002582) Erythrocytes [#/volume] in Urine
257
1769
1.67
9.77
3.7
3.0
e6/l
54.8
100.8
0.47
186
1343
(3036489) Thrombin time
60
248
2.54
9.69
2.8
1.8
s
23.0
21.3
0.36
52
219
(3023368) Bacteria identified in Blood by Culture
223
1481
1.71
9.69
4.0
4.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
238
1610
1.69
9.65
3.4
2.8
e6/l
0.3
0.4
0.41
164
1188
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
113
609
2.00
9.63
9.3
7.8
kpa
5.2
5.1
0.58
113
584
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
158
953
1.82
9.57
2.7
2.5
e6/l
0.9
1.1
0.25
82
524
(40768797) Stomach Pathology biopsy report
152
906
1.84
9.57
1.3
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
127
720
1.91
9.33
1.4
1.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
111
606
1.97
9.10
9.1
7.9
mmol/l
0.4
1.2
1.32
94
474
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
226
1535
1.66
8.91
2.4
2.0
mg/l
2.7
2.9
0.71
193
1320
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
64
285
2.36
8.81
8.0
10.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
356
2714
1.57
8.63
2.6
2.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
139
835
1.81
8.47
1.5
1.6
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
31
98
3.25
8.16
1.3
1.3
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
152
956
1.73
7.88
3.7
3.0
mmol/l
0.8
0.8
0.10
138
897
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
105
592
1.89
7.80
4.3
4.3
u/l
226.2
239.2
0.68
100
563
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
20
49
4.16
7.57
1.5
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
297
2226
1.54
7.48
3.2
3.3
ng/l
26.5
31.7
0.32
176
1365
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
89
483
1.95
7.40
2.9
2.3
ml/min/173m2
80.6
70.3
1.32
37
203
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
166
1087
1.67
7.38
3.4
3.4
ng/l
1651.3
285.5
0.48
112
759
(3026493) Urate [Moles/volume] in Serum or Plasma
222
1573
1.57
7.13
3.0
2.5
umol/l
1456.1
5762.9
2.10
197
1366
(3000991) Gas panel - Venous blood
78
410
2.00
7.11
12.5
8.8
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
111
658
1.80
7.02
26.6
18.8
inr
1.3
1.2
—
10
89
(3015377) Calcium [Moles/volume] in Serum or Plasma
277
2070
1.52
6.96
3.0
3.2
mmol/l
2.4
2.4
1.09
242
1836
(3042936) Bacteria identified in Isolate by Culture
138
874
1.70
6.92
2.2
2.0
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
119
725
1.76
6.85
8.3
6.2
—
—
—
0
0
(4010399)
79
425
1.95
6.74
1.6
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
92
522
1.86
6.69
1.4
1.2
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
22
65
3.45
6.46
1.4
1.2
u/l
39.5
50.1
1.08
15
45
(3001122) Ferritin [Mass/volume] in Serum or Plasma
385
3118
1.46
6.32
3.9
2.7
ug/l
112.4
97.6
0.77
365
2918
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
746
7004
2.28
6.30
13.5
9.5
u/l
28.6
25.3
4.77
731
6787
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
342
2716
1.46
6.17
2.9
2.2
nmol/l
73.1
75.9
1.14
312
2467
(3011397) Hemoglobin [Presence] in Urine by Test strip
203
1453
1.54
6.11
3.6
3.3
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
27
94
2.94
6.10
1.0
1.1
u/ml
5.9
5.7
0.02
12
31
(3002256) Pathology report gross observation
129
830
1.66
6.07
1.3
1.3
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
26
89
2.99
6.05
1.0
1.0
u/ml
0.1
0.1
—
8
19
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
308
2411
1.46
5.93
2.1
1.9
pmol/l
101.2
96.0
0.98
175
1275
(3003888) Timothy IgE Ab [Units/volume] in Serum
32
125
2.63
5.86
1.0
1.1
u/ml
1.7
6.0
1.44
17
56
(3000570) Elastase.pancreatic [Mass/mass] in Stool
42
187
2.32
5.84
1.5
1.4
ug/g
290.2
304.5
0.15
22
109
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
34
138
2.53
5.77
1.1
1.1
u/ml
0.8
1.6
0.79
12
50
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
55
276
2.07
5.71
2.0
2.2
u/l
42.1
40.3
0.31
50
252
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
35
146
2.46
5.62
4.3
2.7
u/ml
0.3
0.4
1.84
16
74
(40758558) Short blood count panel - Blood
220
1627
1.49
5.60
7.5
6.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
49
237
2.14
5.60
1.7
1.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
197
1427
1.51
5.54
1.7
1.6
—
—
—
0
0
(3018418) pH of Serum or Plasma
235
1766
1.47
5.51
5.3
3.8
ph
7.4
7.4
0.44
32
338
(3026008) Bacteria identified in Urine by Culture
243
1839
1.47
5.49
2.7
2.7
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
79
457
1.81
5.41
1.2
1.3
u/ml
116.6
201.3
0.82
72
419
(3008401) Mugwort IgE Ab [Units/volume] in Serum
30
120
2.56
5.26
1.0
1.1
u/ml
0.3
0.9
1.61
11
46
(40761511) CBC panel - Blood by Automated count
737
6947
1.98
5.20
15.9
11.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
71
403
1.84
5.18
1.5
1.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
673
6189
1.61
5.17
14.8
11.0
ml/min/173m2
86.9
85.2
1.14
567
5042
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
152
1058
1.54
5.12
2.9
2.7
mmol/l
2.5
2.4
1.57
137
932
(3044889) 12 lead EKG panel
504
4391
1.41
5.00
3.7
3.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
75
438
1.79
4.99
2.0
2.4
ug/l
7.7
6.2
0.26
66
389
(3021601) Nitrite [Presence] in Urine by Test strip
388
3239
1.39
4.92
5.2
4.5
estimate
0.0
0.0
0.50
56
630
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
18
57
3.21
4.79
1.2
1.0
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
391
3280
1.38
4.76
3.9
3.3
estimate
0.0
0.0
0.50
53
611
(3035350) Ketones [Presence] in Urine by Test strip
386
3234
1.38
4.72
4.0
3.3
estimate
0.0
0.0
0.00
53
625
(3026782) Osmolality of Urine
162
1162
1.50
4.72
3.8
2.5
mosm/kgh2o
537.5
552.3
0.37
136
995
(3013139) Helicobacter pylori Ag [Presence] in Stool
76
456
1.74
4.62
1.2
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
29
122
2.43
4.61
1.1
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
34
155
2.25
4.53
2.6
2.9
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
67
390
1.78
4.52
1.1
1.0
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
26
105
2.53
4.50
1.0
1.0
u/ml
1.5
3.3
0.80
13
31
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
41
203
2.08
4.46
1.3
1.3
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
28
118
2.42
4.44
1.0
1.0
u/ml
0.4
1.8
0.69
11
25
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
197
1486
1.43
4.40
2.8
3.0
ng/l
1348.8
1054.9
0.35
167
1239
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
51
275
1.91
4.38
1.6
1.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
53
290
1.89
4.36
2.7
2.3
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
15
45
3.38
4.34
2.3
3.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
18
61
3.00
4.30
1.3
1.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
106
710
1.57
4.21
1.8
1.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
91
590
1.61
4.14
2.1
2.5
%
1.9
1.8
0.27
81
521
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
27
116
2.37
4.12
2.5
2.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
583
5282
1.40
4.11
4.8
4.1
pmol/l
14.6
14.5
0.12
538
4865
(3043409) Potassium [Moles/volume] in Arterial blood
34
162
2.15
4.09
6.2
3.9
mmol/l
3.8
3.8
0.40
34
150
(3020891) Body temperature
40
204
2.01
4.04
6.2
4.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
167
1240
1.44
4.04
2.9
2.4
e6/l
4.5
7.2
2.58
140
1085
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
226
1774
1.38
3.97
2.1
2.0
u/l
152.5
207.2
0.57
213
1680
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
16
54
3.00
3.86
1.4
1.8
—
—
—
0
0
(3019060) Gas panel - Arterial blood
58
340
1.76
3.85
4.8
5.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
225
1785
1.36
3.67
3.6
3.1
mmol/l
7.7
7.6
0.11
199
1510
(3021960) Folate [Moles/volume] in Serum or Plasma
180
1377
1.40
3.66
1.6
1.5
nmol/l
19.2
21.1
1.05
152
1185
(3006922) Hepatitis E virus Ab [Presence] in Serum
12
35
3.47
3.63
1.2
1.1
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
37
192
1.97
3.59
5.9
4.1
mmol/l
1.1
1.3
1.01
37
186
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
9
17
5.34
3.51
3.4
2.6
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
138
1014
1.44
3.51
1.7
1.7
nmol/l
1127.8
1196.4
0.41
108
777
(4306422)
24
106
2.30
3.48
1.4
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
663
6198
1.45
3.47
5.8
4.8
mu/l
1.7
2.0
0.93
621
5760
(3017446) Testosterone [Moles/volume] in Serum or Plasma
54
322
1.73
3.40
3.5
2.1
nmol/l
12.3
12.0
0.08
45
292
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
89
602
1.54
3.40
1.8
1.8
—
—
—
0
0
(3012544) pH of Venous blood
73
474
1.60
3.33
4.4
3.5
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
40
221
1.85
3.25
1.8
1.4
g/l
1.3
1.2
0.72
40
209
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
11
33
3.37
3.20
1.2
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
11
33
3.37
3.20
1.2
1.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
57
352
1.67
3.18
1.4
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
72
473
1.57
3.14
3.7
3.3
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
9
20
4.54
3.12
1.1
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
71
466
1.58
3.11
2.1
2.5
e9/l
4.3
4.0
0.45
49
381
(3023520) Reticulocytes [#/volume] in Blood
65
420
1.60
3.04
2.4
2.5
e9/l
67.7
72.5
0.71
51
318
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
12
40
3.03
2.98
5.3
7.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
90
629
1.49
2.97
1.7
1.8
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
24
114
2.14
2.97
1.2
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
32
570
0.54
2.96
4.5
3.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
89
622
1.49
2.94
1.6
1.7
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
159
1235
1.36
2.91
1.3
1.3
iu/ml
28.1
31.7
0.15
44
397
(3019225) pH of Specimen
85
592
1.49
2.86
4.1
3.6
—
—
—
0
0
(4268621)
18
77
2.37
2.83
2.9
2.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
211
1716
1.31
2.82
4.5
4.0
mg/mmol
16.3
9.3
0.63
150
1074
(3002032) Base excess in Venous blood by calculation
69
461
1.54
2.81
4.6
3.5
mmol/l
2.2
2.0
0.22
57
362
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
69
462
1.54
2.79
3.2
3.4
pmol/l
4.4
4.5
0.55
62
405
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
25
124
2.05
2.79
1.6
1.2
u/ml
2.0
6.1
1.00
12
43
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
49
302
1.66
2.78
1.6
1.7
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
41
242
1.73
2.72
1.3
1.4
—
4.1
—
0
5
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
28
147
1.94
2.68
1.2
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
201
1636
1.31
2.66
3.8
3.3
mg/l
588.4
373.5
0.24
141
1038
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
632
5932
1.33
2.63
6.5
5.2
mmol/mol
39.8
39.0
1.11
598
5565
(3007461) Platelets [#/volume] in Blood
759
7373
1.86
2.63
26.1
18.2
e9/l
267.4
257.4
3.28
743
7213
(3036481) Cortisol [Moles/volume] in Serum or Plasma
88
628
1.45
2.63
2.0
2.0
nmol/l
409.6
371.4
0.80
74
583
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
120
908
1.38
2.58
1.8
1.8
—
—
—
0
0
(3024731) MCV [Entitic volume]
759
7376
1.84
2.58
26.1
18.1
fl
90.3
90.7
1.76
751
7287
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
155
1222
1.33
2.56
1.7
1.6
—
—
—
0
0
(3035941) MCH [Entitic mass]
759
7377
1.84
2.56
26.0
18.1
pg
30.0
30.2
3.49
751
7287
(3026361) Erythrocytes [#/volume] in Blood
759
7378
1.84
2.55
26.1
18.2
e12/l
4.5
4.5
0.42
744
7202
(3016650) Hepatitis A virus Ab [Presence] in Serum
22
108
2.07
2.53
1.1
1.1
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
759
7379
1.83
2.53
26.2
18.2
e9/l
7.1
6.6
5.82
744
7195
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
69
473
1.50
2.52
1.7
1.7
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
38
225
1.72
2.51
2.1
2.2
g/l
1.5
1.5
0.03
32
193
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
150
1182
1.33
2.49
1.3
1.3
u/ml
19.3
11.2
0.46
66
472
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
21
102
2.09
2.49
1.2
1.0
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
11
39
2.85
2.48
1.1
1.1
u/ml
1.6
0.2
—
5
14
(3000963) Hemoglobin [Mass/volume] in Blood
759
7382
1.82
2.48
26.3
18.3
g/l
134.5
134.9
0.45
752
7287
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
30
166
1.84
2.48
1.2
1.3
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
23
116
2.01
2.48
1.6
1.2
u/ml
1.4
3.8
—
8
36
(3038177) Helicobacter pylori Ab [Presence] in Serum
24
123
1.98
2.47
1.0
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
173
1393
1.31
2.47
4.8
3.6
kg/l
1.0
1.0
0.54
21
191
(3025941) Bacteria identified in Stool by Culture
59
393
1.54
2.46
1.3
1.2
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
6
12
5.03
2.40
1.8
2.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
9
27
3.36
2.39
1.0
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
37
221
1.71
2.38
1.2
1.2
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
56
372
1.54
2.37
1.1
1.1
—
167.3
—
0
7
(3013512) EKG study
201
1661
1.28
2.35
4.0
3.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
105
790
1.38
2.35
1.3
1.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
600
5624
1.28
2.30
21.0
14.9
%
13.7
13.6
0.35
595
5526
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
12
47
2.58
2.28
1.6
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
684
6530
1.37
2.27
4.8
4.1
mmol/l
4.7
4.7
0.39
647
6124
(3037692) Legionella sp identified in Specimen by Organism specific culture
8
23
3.50
2.27
1.5
1.2
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
7
18
3.91
2.25
1.0
1.1
%
92.7
103.9
—
7
18
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
7
18
3.91
2.25
1.0
1.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
326
2864
1.24
2.23
9.4
8.6
e9/l
0.0
0.0
0.21
258
2362
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
5
9
5.58
2.21
1.6
1.8
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
659
6264
1.32
2.20
4.3
3.6
mmol/l
1.4
1.3
5.42
614
5823
(3034426) Prothrombin time (PT)
8
24
3.36
2.18
1.8
1.3
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
7
19
3.71
2.15
1.0
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
680
6497
1.35
2.15
4.7
4.0
mmol/l
1.5
1.5
1.58
637
6067
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
37
230
1.64
2.09
6.0
3.5
mmol/l
24.6
24.2
0.46
32
207
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
177
1460
1.27
2.09
1.6
1.4
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
5
10
5.02
2.07
2.0
3.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
6
159
0.37
2.04
1.7
1.5
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
12
50
2.42
2.03
2.8
2.4
e9/l
1.5
1.2
—
6
25
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
8
26
3.10
2.01
1.1
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
201
1690
1.25
2.01
1.7
1.6
mmol/l
1.6
1.4
2.28
184
1442
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
15
70
2.17
1.99
4.0
4.9
u/ml
11.1
59.8
—
5
23
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
60
422
1.46
1.98
1.3
1.3
—
34.2
—
0
23
(3025468) Yersinia sp identified in Specimen by Organism specific culture
17
84
2.05
1.97
1.3
1.3
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
6
16
3.77
1.93
1.0
1.1
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
6
16
3.77
1.93
3.0
1.8
ug/l
59.2
56.7
—
6
16
(3052851) Hemolysis interference index of Serum or Plasma
28
165
1.72
1.93
2.9
3.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
17
85
2.02
1.91
1.3
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
17
85
2.02
1.91
1.3
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
21
114
1.87
1.88
2.5
4.8
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
12
52
2.33
1.88
1.0
1.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
39
253
1.57
1.88
2.8
3.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
17
86
2.00
1.86
1.3
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
17
86
2.00
1.86
1.3
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
17
86
2.00
1.86
1.3
1.3
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
34
214
1.62
1.85
2.7
5.9
%
1.7
1.6
0.29
34
199
(3007930) Methemoglobin/Hemoglobin.total in Blood
34
214
1.62
1.85
2.6
5.9
%
0.9
0.9
0.27
34
199
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
287
2527
1.21
1.84
4.3
3.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
72
533
1.39
1.81
1.5
1.4
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
7
23
3.06
1.80
1.1
1.2
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
28
169
1.68
1.79
3.4
7.3
mmol/l
1.2
1.2
0.15
28
149
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
97
754
1.33
1.79
4.4
4.0
%
31.3
32.3
0.34
64
524
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
33
209
1.60
1.76
1.8
2.1
ug/l
5.3
3.1
0.21
26
186
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
42
610
0.67
1.76
3.2
3.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
5
13
3.86
1.71
1.6
1.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
52
368
1.44
1.69
1.7
2.0
u/l
5712.2
4039.4
0.18
15
153
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
30
188
1.62
1.68
1.5
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
51
360
1.45
1.68
2.1
2.4
—
—
—
0
0
(3039000) Anion gap in Blood
21
119
1.79
1.67
3.0
8.1
mmol/l
11.6
11.1
0.25
21
107
(3018572) Chloride [Moles/volume] in Blood
21
119
1.79
1.67
3.0
8.1
mmol/l
103.0
105.2
1.03
21
107
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
687
6620
1.30
1.67
5.3
4.5
mmol/l
2.8
2.8
1.28
646
6178
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
8
31
2.60
1.66
1.5
2.5
u/ml
4819.0
657.5
—
8
31
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
8
31
2.60
1.66
3.5
2.7
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
29
182
1.62
1.62
1.4
1.2
u/ml
1.6
3.0
—
5
22
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
659
6325
1.26
1.60
4.8
4.2
mmol/l
5.9
5.8
0.77
617
5851
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
15
77
1.97
1.60
1.1
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
14
70
2.02
1.60
1.1
1.1
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
60
441
1.39
1.59
2.3
3.0
g/l
66.4
67.4
0.53
53
401
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
191
1.59
1.59
2.7
2.0
g/l
2.8
3.1
2.07
23
149
(3023323) Follitropin [Units/volume] in Serum or Plasma
64
477
1.37
1.57
1.4
1.3
iu/l
24.7
28.8
0.49
54
413
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
33
216
1.55
1.56
1.5
1.6
iu/ml
0.1
0.0
—
10
37
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
16
85
1.90
1.56
1.0
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
12
57
2.12
1.55
1.1
1.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
29
186
1.58
1.50
1.4
1.2
u/ml
5.1
10.7
—
8
34
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
12
58
2.09
1.49
1.1
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
39
269
1.47
1.47
1.9
1.6
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
11
52
2.13
1.45
2.7
4.3
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
6
22
2.74
1.43
38.8
25.1
ug/l
6.9
7.2
—
6
17
(3009542) Hematocrit [Volume Fraction] of Blood
644
6186
1.23
1.42
20.1
13.0
%
39.8
39.9
0.05
500
4741
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
506
4758
1.18
1.41
3.7
3.4
—
—
—
0
0
(4062490)
13
67
1.96
1.39
1.5
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
94
756
1.28
1.38
1.5
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
45
325
1.41
1.35
1.5
1.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
30
200
1.52
1.34
3.4
2.6
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
15
83
1.82
1.32
1.1
1.2
nmol/l
0.5
0.5
0.34
15
78
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
6
24
2.51
1.30
1.3
1.7
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
6
24
2.51
1.30
1.3
1.7
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
6
24
2.51
1.30
1.3
1.8
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
9
43
2.11
1.30
1.3
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
31
211
1.49
1.27
1.2
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
9
44
2.06
1.27
1.0
1.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
203
1.50
1.26
2.7
1.9
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
203
1.50
1.26
2.7
1.9
g/l
3.7
3.8
0.16
23
145
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
203
1.50
1.26
2.7
1.9
g/l
6.7
7.4
1.82
23
155
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
33
229
1.46
1.24
1.4
2.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
218
1934
1.18
1.23
1.4
1.5
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
19
2.64
1.21
1.8
1.5
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
19
2.64
1.21
1.2
1.9
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
20
124
1.63
1.21
1.7
1.4
—
—
—
0
0
(3000492) Spirometry study
81
652
1.27
1.20
1.5
1.4
—
—
—
0
0
(4281824)
13
71
1.84
1.20
1.4
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
18
109
1.67
1.19
2.2
1.5
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
6
26
2.32
1.19
1.7
1.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
32
224
1.45
1.16
1.3
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
34
0.00
1.16
0.0
2.6
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
13
72
1.82
1.15
1.9
1.4
—
37.2
—
0
5
(3041806) Other cells [#/volume] in Blood by Manual count
5
20
2.51
1.15
1.6
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
92
757
1.24
1.14
3.1
2.8
ug/l
0.9
0.7
0.84
64
484
(1002224) Polysomnography panel
45
337
1.36
1.12
1.0
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
22
143
1.55
1.12
1.4
1.4
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
10
51
1.97
1.11
1.4
1.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
10
51
1.97
1.11
1.2
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
45
338
1.35
1.11
3.1
3.1
mmol/l
1.3
1.7
0.30
36
253
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
123
1048
1.21
1.10
4.3
4.1
%
21.3
21.6
0.12
71
471
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
27
185
1.48
1.09
2.9
2.0
g/l
9.9
10.7
0.56
22
160
(3011288) Drugs identified in Urine by Screen method
27
185
1.48
1.09
1.9
1.7
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
81
1.74
1.09
1.4
1.6
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
47
357
1.34
1.08
3.1
3.2
kpa
5.2
5.1
0.16
40
338
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
5
22
2.28
1.03
1.0
1.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
231
2546
0.87
1.03
2.4
2.6
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
10
53
1.90
1.01
1.5
1.4
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
9
48
1.88
1.00
1.1
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
194
1735
1.16
0.99
4.8
3.6
estimate
0.0
0.0
1.08
54
619
(3016018) Differential panel - Cerebral spinal fluid
11
61
1.81
0.98
1.0
1.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
149
1306
1.17
0.98
5.5
4.7
ug/l
2.8
2.2
0.63
138
1165
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
118
1014
1.19
0.98
2.2
2.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
16
100
1.61
0.97
1.4
1.7
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
9
50
1.81
0.97
1.9
1.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
21
141
1.50
0.95
1.5
1.6
—
—
—
0
0
(44813793)
9
51
1.77
0.94
1.1
1.0
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
18
117
1.55
0.94
1.3
1.2
u/ml
176.5
274.1
—
8
71
(44806118)
12
70
1.73
0.93
1.6
1.5
—
—
—
0
0
(44790047)
12
70
1.73
0.93
1.6
1.5
—
—
—
0
0
(44790049)
12
70
1.73
0.93
1.6
1.5
—
—
—
0
0
(44790048)
12
70
1.73
0.93
1.6
1.5
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
6
28
2.15
0.91
1.0
1.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
28
2.15
0.91
1.7
1.7
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
28
2.15
0.91
1.7
1.7
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
20
135
1.49
0.90
2.9
2.4
ug/min
78.0
129.0
0.38
13
80
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
19
127
1.51
0.89
1.3
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
13
79
1.66
0.88
1.8
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
12
192
0.62
0.87
2.3
1.7
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
8
44
1.83
0.86
1.1
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
15
96
1.57
0.85
1.7
1.5
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
6
31
1.94
0.84
1.0
1.1
g/l
0.3
0.3
—
6
26
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
8
45
1.79
0.84
1.0
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
10
57
1.76
0.84
1.3
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
10
57
1.76
0.84
1.3
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
10
57
1.76
0.84
1.3
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
8
138
0.58
0.84
1.1
1.9
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
27
197
1.38
0.83
1.2
1.2
u/l
11.6
11.8
0.03
18
157
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
17
113
1.52
0.82
1.6
1.3
u/ml
93.5
113.8
—
5
26
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
11
65
1.70
0.82
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
11
65
1.70
0.82
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
11
65
1.70
0.82
1.1
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
105
1.53
0.82
1.3
1.6
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
16
105
1.53
0.82
1.1
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
16
105
1.53
0.82
1.1
1.3
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
8
47
1.71
0.81
1.5
2.0
—
0.9
—
0
5
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
105
912
1.17
0.79
2.0
1.9
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
173
1560
1.14
0.79
2.9
4.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
37
472
0.77
0.79
1.4
1.5
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
11
66
1.68
0.79
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
11
66
1.68
0.79
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
11
66
1.68
0.79
1.1
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
21
148
1.43
0.78
1.4
1.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
7
123
0.57
0.78
4.3
2.4
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
34
1.77
0.76
1.3
1.6
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
6
34
1.77
0.76
2.7
2.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
34
1.77
0.76
1.3
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
34
1.77
0.76
1.3
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
34
1.77
0.76
1.3
1.6
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
10
59
1.70
0.76
1.6
1.8
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
11
67
1.65
0.75
1.3
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
28
210
1.35
0.74
4.2
3.2
g/l
0.2
0.3
0.09
13
79
(3000764) Benzodiazepines [Presence] in Urine
36
281
1.29
0.74
1.4
1.4
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
20
142
1.42
0.73
1.5
1.5
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
5
25
2.01
0.72
1.4
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
141
1262
1.14
0.72
1.6
1.7
pmol/l
414.0
31814382.4
1.57
122
1075
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
7
39
1.80
0.72
2.1
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
36
282
1.29
0.72
1.4
1.4
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
9
57
1.59
0.71
1.0
1.0
mg/l
180.2
219.1
—
9
46
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
57
1.59
0.71
1.6
3.4
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
26
1.93
0.70
1.0
2.8
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
26
195
1.34
0.70
1.3
1.2
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
9
58
1.56
0.70
1.1
1.5
nmol/l
1.5
1.5
—
9
51
(3028300) Cannabinoids [Presence] in Urine
36
284
1.28
0.69
1.4
1.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
10
61
1.65
0.68
1.4
1.1
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
7
42
1.67
0.68
1.1
1.1
—
13.0
—
0
5
(3006653) Thiamine [Moles/volume] in Blood
5
28
1.79
0.66
2.0
1.4
nmol/l
140.6
145.5
—
5
28
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
8
128
0.62
0.64
1.9
4.0
%
59.0
57.1
—
8
128
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
29
1.73
0.64
1.0
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
21
280
0.74
0.64
1.5
1.9
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
24
181
1.34
0.63
1.2
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
26
199
1.32
0.63
1.3
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
6
101
0.59
0.62
4.2
2.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
38
307
1.25
0.62
1.4
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
30
1.67
0.61
1.2
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
30
1.67
0.61
1.2
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
35
281
1.26
0.60
1.4
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
33
263
1.27
0.60
1.4
1.4
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
10
64
1.57
0.58
5.1
2.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
25
193
1.31
0.58
1.3
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
8
54
1.49
0.57
1.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
6
36
1.67
0.56
1.3
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
11
73
1.51
0.56
1.5
1.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
8
126
0.63
0.54
1.9
3.6
e9/l
4.7
4.3
—
8
126
(3039443) Prostate specific Ag panel - Serum or Plasma
12
82
1.47
0.54
1.6
1.7
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
9
60
1.51
0.54
1.2
1.1
mg/l
33.4
31.9
—
9
46
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
21
160
1.32
0.54
1.1
1.3
mmol/l
4.0
3.7
0.60
21
147
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
6
39
1.54
0.53
1.0
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
16
117
1.38
0.52
1.6
1.6
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
12
83
1.45
0.52
2.8
2.6
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
6
40
1.50
0.51
3.0
2.3
ml
645.5
546.4
—
6
21
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
20
154
1.31
0.49
1.4
1.4
u/l
23.9
28.3
0.24
15
129
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
29
235
1.24
0.48
1.8
1.8
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
11
76
1.45
0.48
1.1
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
32
263
1.23
0.48
1.3
1.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
17
222
0.76
0.48
1.5
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
21
266
0.78
0.47
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
21
266
0.78
0.47
1.3
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
12
85
1.42
0.47
1.6
1.5
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
37
310
1.20
0.46
1.4
1.7
mg/l
4.0
3.2
0.24
28
211
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
16
120
1.34
0.46
1.9
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
21
265
0.79
0.46
1.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
21
265
0.79
0.46
1.3
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
7
49
1.43
0.46
1.6
1.6
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
7
49
1.43
0.46
3.4
2.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
26
211
1.24
0.44
1.7
1.7
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
18
139
1.30
0.44
1.1
1.4
nmol/l
0.3
0.4
0.65
13
111
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
22
175
1.26
0.43
1.1
1.4
mg/l
467.8
436.8
0.13
22
163
(21494890) Protein electrophoresis panel - 24 hour Urine
8
56
1.43
0.42
2.5
2.6
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
5
32
1.57
0.42
1.0
1.1
%
100.8
115.1
—
5
27
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
32
1.57
0.42
1.6
2.1
%
182.1
121.5
—
5
32
(3016750) Collection duration of Urine
5
33
1.52
0.41
2.6
2.3
min
510.2
494.3
—
5
20
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
0
16
0.00
0.41
0.0
1.1
—
35.1
—
0
10
(3045142) Bone marrow Pathology biopsy report
8
59
1.36
0.41
1.9
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
63
560
1.14
0.40
1.2
1.2
iu/ml
151.2
160.1
0.05
23
231
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
5
34
1.47
0.40
1.4
1.4
mmol/l
5.1
5.7
—
5
34
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
5
34
1.47
0.40
1.0
1.8
—
69.4
—
0
5
(3042111) Morphology [Interpretation] in Bone marrow Narrative
12
88
1.37
0.40
1.7
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
23
187
1.24
0.39
1.1
1.1
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.7
—
2.1
—
0
7
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
13
98
1.33
0.37
1.1
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
10
72
1.39
0.37
1.3
1.2
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
6
43
1.40
0.35
2.7
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
157
1480
1.08
0.33
1.9
1.9
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
14
109
1.29
0.33
1.8
1.7
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
14
109
1.29
0.33
1.2
1.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
74
810
0.90
0.33
1.4
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
24
285
0.84
0.33
4.1
2.9
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
7
52
1.35
0.31
1.7
1.3
mmol/l
5.9
6.4
—
7
47
(4146454)
7
52
1.35
0.31
4.3
2.9
—
—
—
0
0
(4027681)
7
52
1.35
0.31
1.0
1.2
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
17
138
1.24
0.30
1.6
1.6
e6/l
6111.9
15400.7
—
10
104
(3047352) Trisomy 18 risk [Likelihood] in Fetus
18
218
0.82
0.30
1.3
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
16
129
1.25
0.30
1.6
1.7
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
7
54
1.30
0.30
1.4
1.1
—
79.0
—
0
6
(3005033) Fetal Nuchal fold Thickness US
18
217
0.83
0.29
1.3
1.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
7
57
1.23
0.29
2.4
1.6
—
—
—
0
0
(40768793) Breast Pathology biopsy report
15
184
0.81
0.29
1.4
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
34
298
1.15
0.29
1.1
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
12
94
1.28
0.28
1.3
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
19
225
0.84
0.26
1.4
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
89
830
1.08
0.26
1.9
1.8
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
10
77
1.30
0.26
1.1
1.6
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
72
0.69
0.26
1.0
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
44
487
0.90
0.25
1.4
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
13
105
1.24
0.25
2.1
1.6
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
9
76
1.19
0.24
1.0
1.8
—
—
—
0
0
(4034850)
18
212
0.85
0.24
3.6
8.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
25
286
0.87
0.24
1.4
1.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
38
1.32
0.23
1.4
1.8
%
11.0
11.5
—
5
38
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
41
1.22
0.22
1.2
1.3
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
35
315
1.12
0.21
1.3
1.6
mu/l
251.5
312.2
1.15
30
284
(3024928) Oxygen saturation in Venous blood
13
107
1.22
0.21
4.2
2.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
192
1851
1.05
0.21
3.6
2.9
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
29
325
0.89
0.21
1.6
1.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
42
1.19
0.21
1.8
1.7
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
5
42
1.19
0.21
2.8
1.3
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
11
0.00
0.21
0.0
6.3
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
10
0.00
0.21
0.0
2.9
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
10
0.00
0.21
0.0
5.8
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
8
103
0.77
0.21
1.0
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
43
1.16
0.21
1.0
1.4
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
13
0.00
0.21
0.0
2.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
37
407
0.90
0.20
2.2
2.5
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
6
48
1.25
0.20
1.0
2.0
—
44.6
—
0
7
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
6
48
1.25
0.20
1.7
1.1
—
1.0
—
0
18
(3003129) Base excess in Capillary blood by calculation
0
14
0.00
0.20
0.0
1.3
—
2.5
—
0
14
(3020191) Ethanol [Moles/volume] in Serum or Plasma
6
49
1.23
0.20
1.0
1.4
promille
1.2
1.4
—
6
38
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
12
99
1.22
0.19
1.2
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
11
90
1.23
0.19
1.1
1.2
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
14
118
1.19
0.19
1.3
1.1
—
11.6
—
0
13
(3006442) Creatine [Moles/volume] in Serum or Plasma
6
52
1.16
0.19
1.3
1.3
—
62.3
—
0
8
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
13
109
1.20
0.18
1.3
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
7
63
1.11
0.17
1.6
1.7
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
8
70
1.14
0.16
2.8
2.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
11
92
1.20
0.16
1.1
1.6
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
11
93
1.19
0.14
1.3
1.5
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
51
480
1.07
0.14
4.5
3.5
mmol/l
1.2
1.2
0.28
46
414
(3021440) Promyelocytes/100 leukocytes in Blood
50
471
1.07
0.13
3.5
4.3
%
0.1
0.1
0.16
11
138
(3019832) Treponema pallidum Ab [Presence] in Serum
82
856
0.95
0.13
1.6
1.6
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
21
190
1.11
0.13
1.5
2.0
iu/l
1.8
4.9
—
5
73
(4094501)
14
158
0.88
0.12
1.2
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
12
105
1.15
0.11
1.1
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
16
145
1.11
0.09
1.0
1.7
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
48
459
1.05
0.08
3.2
4.1
%
0.0
0.6
—
8
114
(3032773) Endomysium IgG Ab [Titer] in Serum
5
63
0.79
0.08
1.0
1.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
30
283
1.06
0.08
1.8
1.7
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
7
65
1.08
0.08
2.9
2.8
u/ml
13.3
60.2
—
7
65
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
66
1.06
0.08
1.0
1.1
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
6
71
0.84
0.07
3.3
2.5
mmol/l
4.6
4.0
—
6
71
(3035285) Chloride [Moles/volume] in Venous blood
6
71
0.84
0.07
3.3
2.5
mmol/l
107.8
106.0
—
6
71
(3033705) Calcium.ionized [Moles/volume] in Venous blood
6
70
0.86
0.07
3.3
2.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
30
284
1.06
0.07
1.1
1.3
miu/ml
221.1
247.1
0.23
16
137
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
7
82
0.85
0.07
1.1
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
67
689
0.97
0.06
1.5
1.6
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
44
453
0.97
0.04
3.3
4.4
%
0.0
0.9
—
9
117
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
17
162
1.05
0.02
1.2
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
41
402
1.02
0.01
1.5
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
126
0.95
0.00
1.8
1.8
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
13
136
0.96
0.00
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
13
136
0.96
0.00
1.1
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
14
145
0.96
0.00
5.9
3.9
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
17
165
1.03
0.00
1.5
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
49
495
0.99
0.00
1.9
1.8
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
10
102
0.98
0.00
1.2
1.1
—
72.8
—
0
25
(3047007) Chlamydophila sp Ab [Presence] in Serum
11
112
0.98
0.00
1.6
1.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
50
504
0.99
0.00
3.5
4.2
%
1.1
1.0
0.02
11
154
(44816559) Phosphatidylethanol [Mass/volume] in Blood
14
142
0.99
0.00
1.0
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
13
129
1.01
0.00
1.5
1.7
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
19.2
—
0
6
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3001729) Color of Synovial fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
6.8
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
42.2
—
0
6
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
8
0.00
0.00
0.0
3.1
—
0.5
—
0
8
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
61
0.98
0.00
1.0
2.2
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
9
0.00
0.00
0.0
3.1
—
—
—
0
0
(4024509)
5
50
1.00
0.00
2.0
1.3
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
9
0.00
0.00
0.0
6.1
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
51
0.98
0.00
1.2
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
13
130
1.00
0.00
1.0
1.0
u/ml
1.6
2.2
—
6
63
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
6
63
0.95
0.00
1.8
1.7
pg
32.2
32.3
—
6
63
(3023419) Bacteria identified in Sputum by Culture
7
71
0.99
0.00
2.0
2.2
—
—
—
0
0
(40758358) Immune stain study
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.9
—
94.3
—
0
7
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
5
0.00
0.00
0.0
1.4
—
2.7
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_LIVER and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_LIVER | 1.688 [1.43, 2.0] | < 0.001 |
| Birth year | 0.997 [0.99, 1.01] | 0.509 |
During the follow-up period (1.1.1998 — 31.12.2019), 253 out of 2095 females with CD2_BENIGN_LIVER died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_LIVER | 1.949 [1.56, 2.44] | < 0.001 |
| Birth year | 0.991 [0.98, 1.0] | 0.054 |
During the follow-up period (1.1.1998 — 31.12.2019), 245 out of 876 males with CD2_BENIGN_LIVER died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_LIVER.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.149% | 0.446% |
| 5 | 0.979% | 2.341% |
| 10 | 2.673% | 6.015% |
| 15 | 5.274% | 11.44% |
| 20 | 9.294% | 19.489% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_LIVER – Benign neoplasm: Liver
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data